ISPOR US 2026
Meet UBC at Booth #317
UBC partners with sponsors to design and implement evidence development programs that generate actionable insights for regulatory and market access decisions. Our integrated approach combines real-world data collection, observational research, and advanced analytics to support the entire product lifecycle.
- Evidence Development Solutions: Registries, observational studies, and real-world evidence strategies tailored to regulatory and payer needs.
- Health Economics & Outcomes Research Support: Data-driven insights for value demonstration and reimbursement strategies.
- Integrated Approach: Linking evidence generation with patient engagement and safety for comprehensive program support.
- Proven Expertise: Decades of experience delivering high-quality evidence across therapeutic areas.
Connect with UBC at ISPOR US 2026 to learn how our evidence development solutions can support your HEOR and market access goals.
Schedule a Meeting
To use these forms you must accept all cookies
Learn More About UBC
We are dedicated to uniting evidence and access for biopharma. Fill out the form to get in touch with our team and learn more.
Other Events
Trade & Channel Strategies 2026
Operationalise: Early Access Programmes Summit Europe 2026
ASH Annual Meeting 2026
Schedule a Meeting
Thank You for Connecting with UBC
.
What You Can Expect Next
.
- Leverage automation to move fast
- Always give customers a human to chat to
- Automate customer support and close leads faster
Get Ready to Change Your Business
.
Service Request
Bekki Bracken Brown
President & Chief Executive Officer
Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.
With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.